A Study of Herceptin (Trastuzumab) Monotherapy in Patients With Metastatic Urothelial Cancer
Status:
Terminated
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the efficacy and safety of intravenous Herceptin in patients with
metastatic urothelial cancer with disease progression during platinum-based chemotherapy. The
anticipated time on study treatment is until disease progression.